Veradigm | MDRX - Le Coût Des Ventes

Prix De L'Action
4.58
Variation Quotidienne
-0.07 -1.40%
Mensuellement
1.78%
Annuel
7.76%
Q1 Prévisions
4.44




Le Coût Des Ventes Changement Date
Alcidion AUD 6.82M 1.16M 2025-12
Ambu A/S DKK 611M 24M 2025-12
Amplifon EUR 460.17M 14.78M 2025-09
Cardinal Health USD 63.36B 1.57B 2025-12
Centene USD 47.59B 831M 2025-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Cigna USD 63.37B 1.93B 2025-09
Coloplast 2.31B 110M 2025-12
Computer Programs Systems USD 42.37M 973K 2024-09
Convatec Group USD 515.3M 270.15M 2024-12
CVS Health USD 92.13B 3.06B 2025-12
Diasorin EUR 99.64M 4.71M 2025-09
Elevance Health USD 38.07B 75M 2025-12
General Electric Aerospace USD 8.92B 654M 2025-12
Gulf Medical Proj AED 151.05M 11.52M 2025-12
Humana USD 26.54B 1.15B 2025-03
IQVIA Holdings USD 3.24B 518M 2025-12
Laboratory Of America USD 2.6B 56.8M 2025-12
Maximus USD 1.05B 61.81M 2025-12
McKesson USD 102.47B 2.86B 2025-12
Med Life RON 283.78M 123.71M 2025-09
Molina Healthcare USD 10.18B 91M 2025-12
Omnicell USD 183.66M 7.53M 2025-12
Oriola-kd EUR 461.6M 35.5M 2025-12
Owens Minor USD 436.92M 32.62M 2025-12
Quest Diagnostics USD 1.93B 27M 2025-12
Rede D'or Sao Luiz BRL 6.29B 4.77B 2025-12
Siemens Healthineers EUR 3.33B 622M 2025-12
Sonova Holding CHF 539.4M 11.5M 2025-12
UnitedHealth USD 92.52B 920M 2025-09
Veeva Systems USD 213.48M 14.01M 2025-12
Veradigm USD 124.74M 56.25M 2022-12
Xerox USD 1.14B 104M 2025-06